News
Escalation of doses of biologic therapies in IBD may be key to improve patient care, showing a good response rate and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback